首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Indian Ayurvedic medicine: Overview and application to brain cancer 印度阿育吠陀医学:概述及在脑癌中的应用
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.101013
Herbert B. Newton

Ayurveda is the traditional medicine system of India, and has been in practice for millennia. It is a traditional approach that uses 1000's of different plant preparations in various combinations for treatment of human ailments, including cancer. Ethnopharmacological and phytochemical analyses are now elucidating the bioactive constituents of the different plant species and herbal formulations, including ashwagandha, curcumin, guduchi, triphala, and others.

To provide an overview of: 1) the ethnopharmacology of Ayurveda and several of its most important plant species and formulations, including pharmacological and molecular mechanisms of its anti-cancer effects; 2) review the literature applying Ayurvedic herbs and formulations to brain tumors.

A detailed PubMed search was performed that included publications involving Ayurveda, cancer, ethnopharmacology, phytochemical analysis, molecular analysis, and brain tumors.

In recent decades, significant research has begun to elucidate the bioactive compounds of ashwagandha, tumeric, guduchi, and triphala, such as withaferin A, withanolides, curcumin, palmatine, and many others. These compounds and extracts are now being applied to brain tumor cells in vitro and in animal models, with positive signs of anti-cancer activity including reduced cell growth, increased apoptosis, cell cycle arrest, increased differentiation, and inhibition of important internal signal transduction pathways.

Several Ayurvedic herbs (ashwagandha, curcumin) have bioactive compounds with significant anti-cancer activity, and are effective in early pre-clinical testing against brain tumor cells in vitro and in animal models. Further pre-clinical testing is warranted, along with advancement into phase I and phase II clinical trials of patients with glioblastoma and other brain tumors.

阿育吠陀是印度的传统医学体系,已有千年历史。阿育吠陀是印度的传统医学体系,已有数千年的历史。它采用传统方法,将 1000 多种不同的植物制剂进行各种组合,用于治疗包括癌症在内的人类疾病。目前,民族药理学和植物化学分析正在阐明不同植物物种和草药配方的生物活性成分,包括灰树叶、姜黄素、古杜奇、三叶草等:1) 阿育吠陀的民族药理学及其几种最重要的植物品种和配方,包括其抗癌作用的药理学和分子机制;2) 综述将阿育吠陀草药和配方应用于脑肿瘤的文献。我们在 PubMed 上进行了详细搜索,包括涉及阿育吠陀、癌症、民族药理学、植物化学分析、分子分析和脑肿瘤的出版物。近几十年来,大量研究已开始阐明灰树叶、吐根、古杜奇和三叶草的生物活性化合物,如含铁血黄素 A、黄烷醇内酯、姜黄素、巴马汀等。目前,这些化合物和提取物正被用于体外和动物模型中的脑肿瘤细胞,并出现了抗癌活性的积极迹象,包括减少细胞生长、增加细胞凋亡、细胞周期停滞、增加分化和抑制重要的内部信号转导途径。一些阿育吠陀草药(灰树花、姜黄素)中的生物活性化合物具有显著的抗癌活性,在早期临床前试验中对体外和动物模型中的脑肿瘤细胞有效。有必要进一步进行临床前试验,并推进对胶质母细胞瘤和其他脑肿瘤患者的 I 期和 II 期临床试验。
{"title":"Indian Ayurvedic medicine: Overview and application to brain cancer","authors":"Herbert B. Newton","doi":"10.1016/j.jaim.2024.101013","DOIUrl":"10.1016/j.jaim.2024.101013","url":null,"abstract":"<div><p>Ayurveda is the traditional medicine system of India, and has been in practice for millennia. It is a traditional approach that uses 1000's of different plant preparations in various combinations for treatment of human ailments, including cancer. Ethnopharmacological and phytochemical analyses are now elucidating the bioactive constituents of the different plant species and herbal formulations, including ashwagandha, curcumin, guduchi, triphala, and others.</p><p>To provide an overview of: 1) the ethnopharmacology of Ayurveda and several of its most important plant species and formulations, including pharmacological and molecular mechanisms of its anti-cancer effects; 2) review the literature applying Ayurvedic herbs and formulations to brain tumors.</p><p>A detailed PubMed search was performed that included publications involving Ayurveda, cancer, ethnopharmacology, phytochemical analysis, molecular analysis, and brain tumors.</p><p>In recent decades, significant research has begun to elucidate the bioactive compounds of ashwagandha, tumeric, guduchi, and triphala, such as withaferin A, withanolides, curcumin, palmatine, and many others. These compounds and extracts are now being applied to brain tumor cells <em>in vitro</em> and in animal models, with positive signs of anti-cancer activity including reduced cell growth, increased apoptosis, cell cycle arrest, increased differentiation, and inhibition of important internal signal transduction pathways.</p><p>Several Ayurvedic herbs (ashwagandha, curcumin) have bioactive compounds with significant anti-cancer activity, and are effective in early pre-clinical testing against brain tumor cells <em>in vitro</em> and in animal models. Further pre-clinical testing is warranted, along with advancement into phase I and phase II clinical trials of patients with glioblastoma and other brain tumors.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 101013"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001281/pdfft?md5=03d9a8aedfb3f5972e5386f43fd69bbf&pid=1-s2.0-S0975947624001281-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142049835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Criteria to select a research “topic” for postgraduate and doctoral studies in ayurveda 选择阿育吠陀研究生和博士生研究 "课题 "的标准
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100978
Sathya N. Dornala , Snehalatha SN. Dornala

A research topic is a subject or problem that an investigator is interested in research. The starting point of any research project that is successful is a well-defined subject of research. The selection of topics is an ongoing approach in which investigators analyse, describe, classify, and refine their ideas. For the ease of selection of topics particularly in the field of Ayurveda, Authors have created an acronym ‘TOPIC’ as a guiding tool for the selection of the area of research. The components of the TOPIC criterion are Textual & Time-bound; Objectivity & Outcome measures; Planning & Pragmatic; Innovative & Interesting and Contemporarily relevant & Consent, highlight useful points for the easy selection of the topic for the research by the novice.

研究课题是研究人员有兴趣研究的主题或问题。任何成功的研究项目的起点都是一个明确的研究课题。选题是一项持续性的工作,研究人员需要对自己的想法进行分析、描述、分类和完善。为了便于选题,尤其是阿育吠陀领域的选题,作者创造了一个缩写词 "TOPIC",作为选择研究领域的指导工具。TOPIC "标准的组成部分包括:文字性& 有时限性; 客观性& 成果衡量标准; 计划性& 实用性; 创新性& 有趣性和当代相关性& 同意,强调了新手轻松选择研究课题的有用要点。
{"title":"Criteria to select a research “topic” for postgraduate and doctoral studies in ayurveda","authors":"Sathya N. Dornala ,&nbsp;Snehalatha SN. Dornala","doi":"10.1016/j.jaim.2024.100978","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100978","url":null,"abstract":"<div><p>A research topic is a subject or problem that an investigator is interested in research. The starting point of any research project that is successful is a well-defined subject of research. The selection of topics is an ongoing approach in which investigators analyse, describe, classify, and refine their ideas. For the ease of selection of topics particularly in the field of Ayurveda, Authors have created an acronym ‘TOPIC’ as a guiding tool for the selection of the area of research. The components of the TOPIC criterion are <strong>T</strong>extual &amp; Time-bound; <strong>O</strong>bjectivity &amp; Outcome measures; Planning &amp; Pragmatic; <strong>I</strong>nnovative &amp; Interesting and <strong>C</strong>ontemporarily relevant &amp; Consent, highlight useful points for the easy selection of the topic for the research by the novice.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100978"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000937/pdfft?md5=2159fcecb239f70886dafd05387a3295&pid=1-s2.0-S0975947624000937-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shilajit mitigates chemotherapeutic drug-induced testicular toxicity: Study on testicular germ cell dynamics, steroidogenesis modulation, and Nrf-2/Keap-1 signaling 夏拉吉减轻化疗药物引起的睾丸毒性:睾丸生殖细胞动力学、类固醇生成调节和Nrf-2/Keap-1信号传导研究
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100930
Arti Rajpoot, Kiran Yadav, Anupam Yadav, Raghav Kumar Mishra

Background

Medications, including chemotherapeutic drugs, contribute to male infertility as external factors by inducing oxidative stress in testicular cells. Shilajit is a naturally occurring bioactive antioxidant used in Ayurvedic medicine to treat a variety of ailments.

Objective

This study examines the potential of Shilajit to counteract the negative effects of the chemotherapeutic drug cyclophosphamide (CPA) on testicular germ cell dynamics.

Material and methods

Male Parkes mice received single intraperitoneal CPA injection (200 mg/kg BW) on day one, followed by daily supplementation of Shilajit (100 and 200 mg/kg BW) for one spermatogenic cycle.

Results

CPA adversely affected testicular germ cell dynamics by inhibiting the conversion of spermatogonia-to-spermatids, altering testicular histoarchitecture, impairing Sertoli cell function and testicular steroidogenesis, and disturbing the testicular oxido-apoptotic balance. Shilajit supplementation restores testicular germ cell dynamics in CPA-exposed mice, as evidenced by improved histoarchitecture of the testis. Shilajit improves testicular daily production and sperm quality by promoting the conversion of spermatogonia (2C) into spermatids (1C), stimulating germ cell proliferation (PCNA), improving Sertoli cell function (N-Cadherin and β-Catenin), and maintaining the Bax/Bcl2 ratio. Additionally, Shilajit enhances testosterone biosynthesis by activating enzymes like 3β-HSD, and 17β-HSD. Shilajit also reduces testicular oxidative stress by increasing antioxidant enzyme activity (SOD) and decreasing lipid peroxidation (LPO). These effects are mediated by upregulation of the antioxidant protein Nrf-2 and downregulation of Keap-1.

Conclusion

The findings underscore the potent androgenic and antioxidant characteristics of Shilajit, as well as its ability to enhance fertility in cases of testicular damage caused by chemotherapeutic drugs.

背景:包括化疗药物在内的药物通过诱导睾丸细胞的氧化应激,作为外部因素导致男性不育。Shilajit是一种天然生物活性抗氧化剂,在阿育吠陀医学中被用于治疗多种疾病:本研究探讨了夏拉杰特抵消化疗药物环磷酰胺(CPA)对睾丸生殖细胞动力学负面影响的潜力:雄性Parkes小鼠在第一天腹腔注射单次CPA(200毫克/千克体重),然后每天补充Shilajit(100和200毫克/千克体重),持续一个生精周期:结果:CPA通过抑制精原细胞向精母细胞的转化、改变睾丸组织结构、损害Sertoli细胞功能和睾丸类固醇生成以及扰乱睾丸氧化-凋亡平衡,对睾丸生精细胞动力学产生了不利影响。睾丸组织结构的改善证明,补充夏拉杰特能恢复暴露于 CPA 的小鼠睾丸生殖细胞的活力。通过促进精原细胞(2C)转化为精子细胞(1C)、刺激生殖细胞增殖(PCNA)、改善Sertoli细胞功能(N-Cadherin和β-Catenin)以及维持Bax/Bcl2比率,夏拉吉提提高了睾丸的日产量和精子质量。此外,夏拉吉通过激活 3β-HSD 和 17β-HSD 等酶来增强睾酮的生物合成。夏拉吉提还能通过提高抗氧化酶活性(SOD)和降低脂质过氧化反应(LPO)来减少睾丸氧化应激。这些作用是通过上调抗氧化蛋白 Nrf-2 和下调 Keap-1 来实现的:结论:研究结果强调了夏拉杰特(Shilajit)的强效雄激素和抗氧化特性,以及在化疗药物导致睾丸损伤的情况下提高生育能力的能力。
{"title":"Shilajit mitigates chemotherapeutic drug-induced testicular toxicity: Study on testicular germ cell dynamics, steroidogenesis modulation, and Nrf-2/Keap-1 signaling","authors":"Arti Rajpoot,&nbsp;Kiran Yadav,&nbsp;Anupam Yadav,&nbsp;Raghav Kumar Mishra","doi":"10.1016/j.jaim.2024.100930","DOIUrl":"10.1016/j.jaim.2024.100930","url":null,"abstract":"<div><h3>Background</h3><p>Medications, including chemotherapeutic drugs, contribute to male infertility as external factors by inducing oxidative stress in testicular cells. Shilajit is a naturally occurring bioactive antioxidant used in Ayurvedic medicine to treat a variety of ailments.</p></div><div><h3>Objective</h3><p>This study examines the potential of Shilajit to counteract the negative effects of the chemotherapeutic drug cyclophosphamide (CPA) on testicular germ cell dynamics.</p></div><div><h3>Material and methods</h3><p>Male Parkes mice received single intraperitoneal CPA injection (200 mg/kg BW) on day one, followed by daily supplementation of Shilajit (100 and 200 mg/kg BW) for one spermatogenic cycle.</p></div><div><h3>Results</h3><p>CPA adversely affected testicular germ cell dynamics by inhibiting the conversion of spermatogonia-to-spermatids, altering testicular histoarchitecture, impairing Sertoli cell function and testicular steroidogenesis, and disturbing the testicular oxido-apoptotic balance. Shilajit supplementation restores testicular germ cell dynamics in CPA-exposed mice, as evidenced by improved histoarchitecture of the testis. Shilajit improves testicular daily production and sperm quality by promoting the conversion of spermatogonia (2C) into spermatids (1C), stimulating germ cell proliferation (PCNA), improving Sertoli cell function (<em>N</em>-Cadherin and β-Catenin), and maintaining the Bax/Bcl2 ratio. Additionally, Shilajit enhances testosterone biosynthesis by activating enzymes like 3β-HSD, and 17β-HSD. Shilajit also reduces testicular oxidative stress by increasing antioxidant enzyme activity (SOD) and decreasing lipid peroxidation (LPO). These effects are mediated by upregulation of the antioxidant protein Nrf-2 and downregulation of Keap-1.</p></div><div><h3>Conclusion</h3><p>The findings underscore the potent androgenic and antioxidant characteristics of Shilajit, as well as its ability to enhance fertility in cases of testicular damage caused by chemotherapeutic drugs.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100930"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000457/pdfft?md5=af3608f199f4c559dca7e0e6ea4faece&pid=1-s2.0-S0975947624000457-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Ayurvedic practices on quality of life of health professionals in Brazil: trends from a quasi experimental study 阿育吠陀疗法对巴西保健专业人员生活质量的影响:一项准实验研究的趋势。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100932
Barbara Esteves das Neves, Nina Claudia Barboza da Silva

Integral health encompasses the way individuals live, considering their quality of life. An inadequate lifestyle can harm human health, increasing the risk of developing chronic non-communicable diseases, which represent 71% of the causes of death worldwide and 54.7% in Brazil. The COVID-19 pandemic has led to impacts on quality of life, resulting from lifestyle changes, especially among health professionals. This constitutes an important factor in the health-disease relationship and the core of the healthcare approach embraced by Ayurveda. The present study evaluated the role of daily Ayurvedic practices in improving the quality of life of health professionals working in the Family Health Strategy of SUS in Paty do Alferes/RJ, Brazil. Ayurveda practices based on Trayopastamba were introduced to 30 health professionals through lectures and guided activities from July to October 2021, spanning three months. Quality of life was assessed using the WHOQOL-BREF questionnaire before and after the intervention. An improvement in perceived quality of life was observed in the physical, psychological, and environmental domains (p > 0.05), while the social domain did not show statistically significant results. The physical domain demonstrated the most substantial score increase (10.95). Conversely, the social domain displayed the smallest rise in scores (5.83). In conclusion, the daily Ayurvedic practices demonstrated the potential to enhance the quality of life in this group, contributing to health promotion in a practical and economically accessible manner.

整体健康包括个人的生活方式,考虑到他们的生活质量。不适当的生活方式会损害人类健康,增加罹患慢性非传染性疾病的风险,这些疾病占全球死亡原因的 71%,在巴西占 54.7%。COVID-19 大流行导致生活方式的改变,对生活质量产生了影响,尤其是在医疗专业人员中。这是健康与疾病关系中的一个重要因素,也是阿育吠陀所采用的保健方法的核心。本研究评估了日常阿育吠陀实践在改善巴西 Paty do Alferes/RJ 卫生系统家庭保健战略中卫生专业人员生活质量方面的作用。2021 年 7 月至 10 月,在为期三个月的时间里,通过讲座和指导活动向 30 名卫生专业人员介绍了以 Trayopastamba 为基础的阿育吠陀实践。在干预前后,使用世界卫生组织生活质量问卷(WHOQOL-BREF)对生活质量进行了评估。结果显示,身体、心理和环境领域的生活质量均有所改善(P > 0.05),而社会领域的结果在统计学上并不显著。身体领域的得分增幅最大(10.95)。相反,社交领域的得分增幅最小(5.83)。总之,日常阿育吠陀疗法显示出了提高该群体生活质量的潜力,有助于以一种实用且经济的方式促进健康。
{"title":"Effects of Ayurvedic practices on quality of life of health professionals in Brazil: trends from a quasi experimental study","authors":"Barbara Esteves das Neves,&nbsp;Nina Claudia Barboza da Silva","doi":"10.1016/j.jaim.2024.100932","DOIUrl":"10.1016/j.jaim.2024.100932","url":null,"abstract":"<div><p>Integral health encompasses the way individuals live, considering their quality of life. An inadequate lifestyle can harm human health, increasing the risk of developing chronic non-communicable diseases, which represent 71% of the causes of death worldwide and 54.7% in Brazil. The COVID-19 pandemic has led to impacts on quality of life, resulting from lifestyle changes, especially among health professionals. This constitutes an important factor in the health-disease relationship and the core of the healthcare approach embraced by Ayurveda. The present study evaluated the role of daily Ayurvedic practices in improving the quality of life of health professionals working in the Family Health Strategy of SUS in Paty do Alferes/RJ, Brazil. Ayurveda practices based on <em>Trayopastamba</em> were introduced to 30 health professionals through lectures and guided activities from July to October 2021, spanning three months. Quality of life was assessed using the WHOQOL-BREF questionnaire before and after the intervention. An improvement in perceived quality of life was observed in the physical, psychological, and environmental domains (p &gt; 0.05), while the social domain did not show statistically significant results. The physical domain demonstrated the most substantial score increase (10.95). Conversely, the social domain displayed the smallest rise in scores (5.83). In conclusion, the daily Ayurvedic practices demonstrated the potential to enhance the quality of life in this group, contributing to health promotion in a practical and economically accessible manner.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100932"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000470/pdfft?md5=9ce32bb7cdd87c8d9de8a8dc5f5c4848&pid=1-s2.0-S0975947624000470-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141457084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical metabolomics investigation of rheumatoid arthritis patients receiving ayurvedic whole system intervention 类风湿性关节炎患者接受阿育吠陀全系统干预的临床代谢组学研究。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.101009
Sanjeev Rastogi , Ankita Verma , Rimjhim Trivedi , Anuj Shukla , Dinesh Kumar
<div><h3>Background</h3><p>Arthritis is a common clinical condition seen in Ayurveda clinics. Clinical trials have reported Ayurvedic interventions to be of benefits in many arthritic conditions including Rheumatoid Arthritis (RA). No mechanistic details however are available about how such interventions on their own or as a combination of whole system Ayurveda might be working. <strong>Objective:</strong> The study aims to evaluate simultaneously the clinical outcome of Ayurveda whole system (AWS) intervention in RA patients and identifying the serum metabolic signatures which could be useful for diagnosing the disease and monitoring treatment response.</p></div><div><h3>Material and methods</h3><p>RA patients (n = 37) simultaneously diagnosed as <em>Amavata</em> fulfilling the specific inclusion and exclusion criteria were recruited in the study and were given Ayurveda whole system (AWS) intervention comprised of oral medicines, local therapy and dietary recommendation for 3 months. The clinical and serum metabolic changes were investigated for pre-treatment RA patients (baseline RA group, n = 37) and post-treatment RA patients (following treatment of 6-weeks (RA_F, n = 26) and three months (RA_T, n = 36). For comparative serum metabolomics analysis, 57 normal healthy control (HC) subjects were also involved and the serum metabolic profiles were measured at high-field 800 MHz NMR spectrometer. The serum metabolic profiles were compared using multivariate statistical analysis and discriminatory metabolic features were evaluated for diagnostic potential using receiver operating characteristic (ROC) curve analysis.</p></div><div><h3>Results</h3><p>A significant reduction in DAS-28 ESR, AAM Score, total swollen joints, total tender joints were observed following AWS intervention. The clinical outcomes were concordant with changes in metabolic profiles of RA patients as these were also shifting towards the normal levels following the intervention. Compared to healthy control (HC) subjects, the sera of baseline RA patients were characterised by increased circulatory level of succinate, lysine, mannose, creatine, and 3-Hydroxybutyrate (3-HB) and decreased levels of alanine. The present study also evaluated the serum metabolic ratios for their discriminatory and diagnostic potential and notably, six metabolic ratios (KHR, KThR, KVR, GHR, PTR and SHR) were found significantly altered (elevated) in baseline RA patients. However, in RA patients receiving AWS treatment, these metabolic changes showed marked convergence towards the metabolic signatures of healthy controls.</p></div><div><h3>Conclusion</h3><p>This first of its kind study clearly shows the clinical efficacy of Ayurvedic Whole System (AWS) intervention in the management of Rheumatoid Arthritis (RA), as demonstrated by significant improvements in key clinical parameters. The intervention not only alleviated symptoms but also induced a profound metabolic shifting towards normalization; thus, und
背景:关节炎是阿育吠陀诊所常见的临床症状。据临床试验报告,阿育吠陀疗法对包括类风湿性关节炎(RA)在内的许多关节炎都有疗效。然而,关于这些干预措施本身或作为整个阿育吠陀系统的组合如何发挥作用,目前尚无机制方面的详细资料:本研究旨在同时评估阿育吠陀全系统(AWS)干预对 RA 患者的临床疗效,并确定有助于诊断疾病和监测治疗反应的血清代谢特征:研究招募了符合特定纳入和排除标准、同时被诊断为Amavata的RA患者(n = 37),对其进行为期3个月的阿育吠陀全系统(AWS)干预,包括口服药物、局部治疗和饮食建议。研究人员调查了治疗前(基线 RA 组,37 人)和治疗后(治疗 6 周(RA_F,26 人)和 3 个月(RA_T,36 人))RA 患者的临床和血清代谢变化。为了进行血清代谢组学对比分析,57 名正常健康对照(HC)受试者也参与其中,并在高场 800 MHz NMR 光谱仪上测量了血清代谢谱。使用多变量统计分析对血清代谢谱进行比较,并使用接收器操作特征曲线(ROC)分析评估代谢特征的鉴别诊断潜力:结果:AWS 干预后,DAS-28 ESR、AAM 评分、关节肿胀总数、关节压痛总数均明显减少。临床结果与 RA 患者新陈代谢状况的变化一致,因为这些变化在干预后也趋于正常水平。与健康对照组(HC)受试者相比,基线 RA 患者血清中琥珀酸、赖氨酸、甘露糖、肌酸和 3-羟丁酸(3-HB)的循环水平升高,丙氨酸水平降低。本研究还评估了血清代谢比率的鉴别和诊断潜力,结果发现,基线 RA 患者的六种代谢比率(KHR、KThR、KVR、GHR、PTR 和 SHR)明显改变(升高)。然而,在接受 AWS 治疗的 RA 患者中,这些代谢变化明显向健康对照组的代谢特征靠拢:这项首创的研究清楚地表明,阿育吠陀全系统(AWS)干预对类风湿关节炎(RA)的临床疗效显著,关键临床参数的显著改善证明了这一点。干预措施不仅缓解了症状,还促使新陈代谢深刻地向正常化转变;因此,强调了阿育吠陀全系统干预措施在调节细胞新陈代谢方面的潜力,从而促进类风湿关节炎患者恢复体内平衡。不过,今后的研究必须证实这些初步观察结果,并阐明对 RA 病例进行干预的潜在作用机制。
{"title":"Clinical metabolomics investigation of rheumatoid arthritis patients receiving ayurvedic whole system intervention","authors":"Sanjeev Rastogi ,&nbsp;Ankita Verma ,&nbsp;Rimjhim Trivedi ,&nbsp;Anuj Shukla ,&nbsp;Dinesh Kumar","doi":"10.1016/j.jaim.2024.101009","DOIUrl":"10.1016/j.jaim.2024.101009","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;p&gt;Arthritis is a common clinical condition seen in Ayurveda clinics. Clinical trials have reported Ayurvedic interventions to be of benefits in many arthritic conditions including Rheumatoid Arthritis (RA). No mechanistic details however are available about how such interventions on their own or as a combination of whole system Ayurveda might be working. &lt;strong&gt;Objective:&lt;/strong&gt; The study aims to evaluate simultaneously the clinical outcome of Ayurveda whole system (AWS) intervention in RA patients and identifying the serum metabolic signatures which could be useful for diagnosing the disease and monitoring treatment response.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Material and methods&lt;/h3&gt;&lt;p&gt;RA patients (n = 37) simultaneously diagnosed as &lt;em&gt;Amavata&lt;/em&gt; fulfilling the specific inclusion and exclusion criteria were recruited in the study and were given Ayurveda whole system (AWS) intervention comprised of oral medicines, local therapy and dietary recommendation for 3 months. The clinical and serum metabolic changes were investigated for pre-treatment RA patients (baseline RA group, n = 37) and post-treatment RA patients (following treatment of 6-weeks (RA_F, n = 26) and three months (RA_T, n = 36). For comparative serum metabolomics analysis, 57 normal healthy control (HC) subjects were also involved and the serum metabolic profiles were measured at high-field 800 MHz NMR spectrometer. The serum metabolic profiles were compared using multivariate statistical analysis and discriminatory metabolic features were evaluated for diagnostic potential using receiver operating characteristic (ROC) curve analysis.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;A significant reduction in DAS-28 ESR, AAM Score, total swollen joints, total tender joints were observed following AWS intervention. The clinical outcomes were concordant with changes in metabolic profiles of RA patients as these were also shifting towards the normal levels following the intervention. Compared to healthy control (HC) subjects, the sera of baseline RA patients were characterised by increased circulatory level of succinate, lysine, mannose, creatine, and 3-Hydroxybutyrate (3-HB) and decreased levels of alanine. The present study also evaluated the serum metabolic ratios for their discriminatory and diagnostic potential and notably, six metabolic ratios (KHR, KThR, KVR, GHR, PTR and SHR) were found significantly altered (elevated) in baseline RA patients. However, in RA patients receiving AWS treatment, these metabolic changes showed marked convergence towards the metabolic signatures of healthy controls.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;This first of its kind study clearly shows the clinical efficacy of Ayurvedic Whole System (AWS) intervention in the management of Rheumatoid Arthritis (RA), as demonstrated by significant improvements in key clinical parameters. The intervention not only alleviated symptoms but also induced a profound metabolic shifting towards normalization; thus, und","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 101009"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001244/pdfft?md5=75bb8a169bb6aeb9c3bdcaa74a6b2dc0&pid=1-s2.0-S0975947624001244-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic inflammation: Cross linking insights from Ayurvedic Sciences, a silver lining to systems biology and personalized medicine 慢性炎症:来自阿育吠陀科学的交叉见解,系统生物学和个性化医学的一线希望
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.101016
Pratibha P. Nair , V Krishnakumar , Parvathy G. Nair

Precision in personalized medicine is a crucial subject that needs comprehensive discussion and scientific validation. Traditional healthcare approaches like the Ayurvedic Sciences are often contextually linked with personalized medicine. However, it is unfortunate that this knowledge concerning Ayurveda and personalized medicine is restricted to applying systems biology techniques to 'prakriti' the phenotypic expression and characterization detailed in the literature. There are other significant constructs besides prakruti that interest an Ayurvedic physician, which accounts for crafting precision in evidence-based medicinal practices. There is this influential model of Ayurvedic healthcare practice wherein the physician maps specific personalized characters in addition to prakruti to deduce the host responses to endogenous and exposome conditions. Subsequently, tailored protocols are administered that bring about holistic, personalized outcomes.

The review aimed to determine the effective methods for integrating Systems Biology, Ayurvedic Sciences, and Personalized Medicine (precision medicinebased). Ayurveda adopts a holistic approach, considering multiple variables and their interconnections, while the modern reductionist approach focuses on understanding complex details of smaller parts through rigorous experimentation. Despite seeming extremes, ongoing research on lifestyle, gut health, and spiritual well-being highlights the evolving intersection between traditional Ayurvedic practices and modern science. The current focus is on developing the fundamental concept of Ayurveda Biology by incorporating Systems Biology techniques.

Challenges in this integration include understanding diverse data types, bridging interdisciplinary knowledge gaps, and addressing technological limitations and ethical concerns. Overcoming these challenges will require interdisciplinary collaboration, innovative methodologies, substantial investment in technology, and cultural sensitivity to preserve Ayurveda's core principles while leveraging modern scientific advancements. The focus of discussions and debates on such collaborations should be breakthrough clinical models, such as chronic inflammation, which can be objectively related to specific stages of disease manifestations described in Ayurveda. Validating patient characteristics with systems biology approaches, particularly in shared pathologies like chronic inflammation, is crucial for bringing prediction and precision to personalized medicine

个性化医疗的精准性是一个需要全面讨论和科学验证的重要课题。像阿育吠陀科学这样的传统保健方法往往与个性化医疗联系在一起。然而,令人遗憾的是,有关阿育吠陀和个性化医疗的知识仅限于将系统生物学技术应用于 "prakriti",即文献中详述的表型表达和特征描述。除了 "prakruti "之外,阿育吠陀医师还对其他重要的结构感兴趣,这也是在循证医学实践中精确制作的原因。阿育吠陀医疗实践中有一种很有影响力的模式,即医生会绘制除prakruti之外的特定个性化特征,以推断宿主对内源性和外源性条件的反应。本综述旨在确定整合系统生物学、阿育吠陀科学和个性化医学(基于精准医学)的有效方法。阿育吠陀采用整体方法,考虑多种变量及其相互联系,而现代还原论方法则侧重于通过严格的实验了解较小部分的复杂细节。尽管看似极端,但对生活方式、肠道健康和精神健康的持续研究凸显了传统阿育吠陀实践与现代科学之间不断发展的交集。目前的重点是通过结合系统生物学技术来发展阿育吠陀生物学的基本概念。这种整合所面临的挑战包括理解不同的数据类型、弥合跨学科知识差距以及解决技术限制和伦理问题。要克服这些挑战,需要跨学科合作、创新方法、大量技术投资和文化敏感性,以便在利用现代科学进步的同时保护阿育吠陀的核心原则。有关此类合作的讨论和辩论重点应该是突破性的临床模型,例如慢性炎症,它可以客观地与阿育吠陀中描述的疾病表现的特定阶段相关联。利用系统生物学方法验证患者特征,尤其是慢性炎症等共同病理特征,对于实现个性化医疗的预测和精准至关重要。
{"title":"Chronic inflammation: Cross linking insights from Ayurvedic Sciences, a silver lining to systems biology and personalized medicine","authors":"Pratibha P. Nair ,&nbsp;V Krishnakumar ,&nbsp;Parvathy G. Nair","doi":"10.1016/j.jaim.2024.101016","DOIUrl":"10.1016/j.jaim.2024.101016","url":null,"abstract":"<div><p>Precision in personalized medicine is a crucial subject that needs comprehensive discussion and scientific validation. Traditional healthcare approaches like the Ayurvedic Sciences are often contextually linked with personalized medicine. However, it is unfortunate that this knowledge concerning Ayurveda and personalized medicine is restricted to applying systems biology techniques to <em>'prakriti'</em> the phenotypic expression and characterization detailed in the literature. There are other significant constructs besides prakruti that interest an Ayurvedic physician, which accounts for crafting precision in evidence-based medicinal practices. There is this influential model of Ayurvedic healthcare practice wherein the physician maps specific personalized characters in addition to prakruti to deduce the host responses to endogenous and exposome conditions. Subsequently, tailored protocols are administered that bring about holistic, personalized outcomes.</p><p>The review aimed to determine the effective methods for integrating Systems Biology, Ayurvedic Sciences, and Personalized Medicine (precision medicinebased). Ayurveda adopts a holistic approach, considering multiple variables and their interconnections, while the modern reductionist approach focuses on understanding complex details of smaller parts through rigorous experimentation. Despite seeming extremes, ongoing research on lifestyle, gut health, and spiritual well-being highlights the evolving intersection between traditional Ayurvedic practices and modern science. The current focus is on developing the fundamental concept of Ayurveda Biology by incorporating Systems Biology techniques.</p><p>Challenges in this integration include understanding diverse data types, bridging interdisciplinary knowledge gaps, and addressing technological limitations and ethical concerns. Overcoming these challenges will require interdisciplinary collaboration, innovative methodologies, substantial investment in technology, and cultural sensitivity to preserve Ayurveda's core principles while leveraging modern scientific advancements. The focus of discussions and debates on such collaborations should be breakthrough clinical models, such as chronic inflammation, which can be objectively related to specific stages of disease manifestations described in Ayurveda. Validating patient characteristics with systems biology approaches, particularly in shared pathologies like chronic inflammation, is crucial for bringing prediction and precision to personalized medicine</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 101016"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001311/pdfft?md5=f2ff834ddb57abe278d544682d15f8fa&pid=1-s2.0-S0975947624001311-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141622182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Heart Revival, an Ayurvedic formulation, in hypertension and related risks – An exploratory single arm open label trial 阿育吠陀配方 "Heart Revival "对高血压及相关风险的疗效--一项探索性单臂开放标签试验。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100975
Srikanta Pandit , Tuhin Kanti Biswas , Sayantan Bera , Sumana Saha , Utpalenedu Jana , Tapas Kumar Sur
{"title":"Efficacy of Heart Revival, an Ayurvedic formulation, in hypertension and related risks – An exploratory single arm open label trial","authors":"Srikanta Pandit ,&nbsp;Tuhin Kanti Biswas ,&nbsp;Sayantan Bera ,&nbsp;Sumana Saha ,&nbsp;Utpalenedu Jana ,&nbsp;Tapas Kumar Sur","doi":"10.1016/j.jaim.2024.100975","DOIUrl":"10.1016/j.jaim.2024.100975","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100975"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000901/pdfft?md5=d5bfeca3069e97581c034e93d8e850f6&pid=1-s2.0-S0975947624000901-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversal of type 2 diabetes mellitus through integrated Ayurveda dietary protocol – A case report 通过阿育吠陀综合饮食方案逆转 2 型糖尿病--病例报告。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100946
Suketha Kumari , Basavaraj R. Tubaki , Rekha S. Patil , S.D. Laxmikant

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder of hyperglycemia has close link with obesity and insulin resistance. Standard approaches in T2DM management are lifestyle management and Pharmacotherapy. Dietary management in T2DM was found to be safe and effective. In India, studies on reversal of T2DM through diet were less found. Presenting a case of female aged 31 years with T2DM (HbA1c-13.5) was successfully reversed diabetes with dietary principles of Indian traditional medicine (Ayurveda diet) and therapeutic yoga practices. Pre and post assessment of Glycaemic parameters (HbA1C, FBS, and PPBS), Lipid profiles, Insulin resistance parameter (HOMA IR) were done. Major outcome of this case is greater reduction of HbA1c from inadequate control to near normal. Marked changes observed in weight, BMI and Waist circumference. A change in Homa IR indicates improvement in insulin resistance. Ayurveda dietary management training include Therapeutic fasting [Two meal method], meals include nutrient dense wholesome food, Indian millet based diet, herbal recipes [therapeutic food/herbal drinks, smoothies and plant juices] and eat only when hungry method. Yoga include complete sequel of body loosening practices, surya namaskara, yogic postures and breathing and meditative techniques practiced for specified period [60 min].This case showed effectiveness of Ayurveda diet and Yoga practices in reversing the insulin resistance, help to maintain the glycemic parameters .In addition, patient was able to loose body weight, waist circumference & serum triglyceride levels. Patient can able to withstand her diabetic profile in normal without any pharmacotherapy intervention.

2 型糖尿病(T2DM)是一种慢性高血糖代谢疾病,与肥胖和胰岛素抵抗密切相关。治疗 T2DM 的标准方法是生活方式管理和药物治疗。研究发现,对 T2DM 进行饮食管理既安全又有效。在印度,通过饮食逆转 T2DM 的研究较少。本文介绍了一例 31 岁女性 T2DM 患者(HbA1c-13.5)通过印度传统医学饮食原则(阿育吠陀饮食)和瑜伽治疗实践成功逆转糖尿病的病例。对血糖参数(HbA1C、FBS 和 PPBS)、血脂概况、胰岛素抵抗参数(HOMA IR)进行了前后评估。该病例的主要结果是 HbA1c 从控制不足降至接近正常。体重、体重指数和腰围都有明显变化。Homa IR 的变化表明胰岛素抵抗有所改善。阿育吠陀饮食管理培训包括治疗性禁食[两餐法],膳食包括营养丰富的健康食物、印度小米饮食、草药食谱[治疗性食物/草药饮料、冰沙和植物果汁]以及饿了才吃的方法。该病例显示,阿育吠陀饮食和瑜伽练习在逆转胰岛素抵抗方面非常有效,有助于维持血糖参数。此外,患者的体重、腰围和血清甘油三酯水平都有所下降。在没有任何药物治疗干预的情况下,患者能够维持正常的糖尿病状况。
{"title":"Reversal of type 2 diabetes mellitus through integrated Ayurveda dietary protocol – A case report","authors":"Suketha Kumari ,&nbsp;Basavaraj R. Tubaki ,&nbsp;Rekha S. Patil ,&nbsp;S.D. Laxmikant","doi":"10.1016/j.jaim.2024.100946","DOIUrl":"10.1016/j.jaim.2024.100946","url":null,"abstract":"<div><p>Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder of hyperglycemia has close link with obesity and insulin resistance. Standard approaches in T2DM management are lifestyle management and Pharmacotherapy. Dietary management in T2DM was found to be safe and effective. In India, studies on reversal of T2DM through diet were less found. Presenting a case of female aged 31 years with T2DM (HbA1c-13.5) was successfully reversed diabetes with dietary principles of Indian traditional medicine (Ayurveda diet) and therapeutic yoga practices. Pre and post assessment of Glycaemic parameters (HbA1C, FBS, and PPBS), Lipid profiles, Insulin resistance parameter (HOMA IR) were done. Major outcome of this case is greater reduction of HbA1c from inadequate control to near normal. Marked changes observed in weight, BMI and Waist circumference. A change in Homa IR indicates improvement in insulin resistance. Ayurveda dietary management training include Therapeutic fasting [Two meal method], meals include nutrient dense wholesome food, Indian millet based diet, herbal recipes [therapeutic food/herbal drinks, smoothies and plant juices] and eat only when hungry method. Yoga include complete sequel of body loosening practices, surya namaskara, yogic postures and breathing and meditative techniques practiced for specified period [60 min].This case showed effectiveness of Ayurveda diet and Yoga practices in reversing the insulin resistance, help to maintain the glycemic parameters .In addition, patient was able to loose body weight, waist circumference &amp; serum triglyceride levels. Patient can able to withstand her diabetic profile in normal without any pharmacotherapy intervention.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100946"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000615/pdfft?md5=624e27ee91ea004294bedd165e215b18&pid=1-s2.0-S0975947624000615-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing efficacy of curcumin with other treatment modalities in oral submucous fibrosis management - A systematic review and meta-analysis 姜黄素与其他治疗方法在口腔黏膜下纤维化治疗中的疗效比较 - 系统综述和荟萃分析。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.100950
Mandavi Waghmare , Sandeep Pagare , Ketaki Bhor , Richa Srivastava , Reema Manoj , Kapil Gavand

Background

Oral Submucous Fibrosis, OSF is an inflammatory mucosal disorder prevalent in areca nut chewing belts of the world. Although various treatments are available for its management, none provide complete resolution.Curcumin, an indigenous product, improves burning sensation, mouth opening along with other clinical signs of OSF and is potentially viable therapeutic option for its management.

Objectives

To assess the available evidence for employing curcumin in improving symptoms in patients with OSF.

Methods

Systematic search was carried out in e-databases from January 2010 until July 2023 to identify relevant clinical trials comparing curcumin to active and/or nonactive controls (placebo) for the management of OSF.

Results

A total of 20 studies were used for qualitative analysis out of which 11 studies were considered for quantitative synthesis.Curcumin was found to be highly effective in alleviating pain/burning sensation, improving mouth opening (MO), cheek flexibility, tongue protrusion and induces positive histological changes in patients with OSF.The standardized mean difference in mouth opening between both the Curcumin and Multivitamin group showed a statistically significant difference favouring the Curcumin group (SMD, 0.37, 95% CI = 0.18–0.56, p - 0.0001, I2- 0%).

Conclusion

Statistically curcumin was noted to be as effective as Aloe vera, lycopene and steroids in relieving symptoms of OSF in stages 1 and 2 and improving MO. It is seen to improve histopathological picture of lesions thereby suggesting its active role in preventing malignant transformation. Its found to be more effective than multivitamins in improving mouth opening of patients in OSF.

背景:口腔黏膜下纤维化(Oral Submucous Fibrosis,OSF)是一种炎症性黏膜疾病,普遍存在于世界上的咀嚼山茶果地带。姜黄素是一种本土产品,可改善灼烧感、张口困难以及其他口腔黏膜纤维化的临床症状,是治疗口腔黏膜纤维化的潜在可行疗法:评估使用姜黄素改善 OSF 患者症状的现有证据:方法:在2010年1月至2023年7月的电子数据库中进行系统检索,以确定姜黄素与活性和/或非活性对照(安慰剂)治疗OSF的相关临床试验:姜黄素在减轻疼痛/灼烧感、改善OSF患者的张口度(MO)、颊部灵活性、舌前伸和诱导组织学变化方面非常有效。姜黄素组和复合维生素组在张口度方面的标准化平均差异显示,姜黄素组的差异具有统计学意义(SMD, 0.37, 95% CI = 0.18-0.56, p - 0.0001, I2-0%):据统计,姜黄素与芦荟、番茄红素和类固醇一样,能有效缓解 OSF 第 1 和第 2 阶段的症状并改善 MO。姜黄素还能改善病变的组织病理学表现,从而表明它在预防恶性转化方面发挥着积极作用。在改善 OSF 患者张口情况方面,它比多种维生素更有效。
{"title":"Comparing efficacy of curcumin with other treatment modalities in oral submucous fibrosis management - A systematic review and meta-analysis","authors":"Mandavi Waghmare ,&nbsp;Sandeep Pagare ,&nbsp;Ketaki Bhor ,&nbsp;Richa Srivastava ,&nbsp;Reema Manoj ,&nbsp;Kapil Gavand","doi":"10.1016/j.jaim.2024.100950","DOIUrl":"10.1016/j.jaim.2024.100950","url":null,"abstract":"<div><h3>Background</h3><p>Oral Submucous Fibrosis, OSF is an inflammatory mucosal disorder prevalent in areca nut chewing belts of the world. Although various treatments are available for its management, none provide complete resolution.Curcumin, an indigenous product, improves burning sensation, mouth opening along with other clinical signs of OSF and is potentially viable therapeutic option for its management.</p></div><div><h3>Objectives</h3><p>To assess the available evidence for employing curcumin in improving symptoms in patients with OSF.</p></div><div><h3>Methods</h3><p>Systematic search was carried out in e-databases from January 2010 until July 2023 to identify relevant clinical trials comparing curcumin to active and/or nonactive controls (placebo) for the management of OSF.</p></div><div><h3>Results</h3><p>A total of 20 studies were used for qualitative analysis out of which 11 studies were considered for quantitative synthesis.Curcumin was found to be highly effective in alleviating pain/burning sensation, improving mouth opening (MO), cheek flexibility, tongue protrusion and induces positive histological changes in patients with OSF.The standardized mean difference in mouth opening between both the Curcumin and Multivitamin group showed a statistically significant difference favouring the Curcumin group (SMD, 0.37, 95% CI = 0.18–0.56, p - 0.0001, I<sup>2</sup>- 0%).</p></div><div><h3>Conclusion</h3><p>Statistically curcumin was noted to be as effective as <em>Aloe vera</em>, lycopene and steroids in relieving symptoms of OSF in stages 1 and 2 and improving MO. It is seen to improve histopathological picture of lesions thereby suggesting its active role in preventing malignant transformation. Its found to be more effective than multivitamins in improving mouth opening of patients in OSF.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 100950"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000652/pdfft?md5=50c24a14b0e5494337fcb0b499a54db6&pid=1-s2.0-S0975947624000652-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antidiabetic effect of combined extract of Coccinia grandis and Blumea balsamifera on streptozotocin-nicotinamide induced diabetic rats 大叶茯苓和苦楝联合提取物对链脲佐菌素-烟酰胺诱导的糖尿病大鼠的抗糖尿病作用
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-01 DOI: 10.1016/j.jaim.2024.101021
I Made Wisnu Adhi Putra , Nanang Fakhrudin , Arief Nurrochmad , Subagus Wahyuono

Background

Coccinia grandis and Blumea balsamifera are two medicinal plants that have been known to have good antidiabetic properties. Combining these two plant extracts may generate a greater effect that can increase efficacy and decrease the dose.

Objective

This research investigated the antidiabetic activity of the combination of C. grandis and B. balsamifera leaves extracts on experimental diabetic rats.

Materials and methods

The dried leaves of C. grandis and B. balsamifera were powdered and macerated with ethanol 70% (v/v). A diabetic condition in male Wistar albino rats was generated by intraperitoneal injection of a single dose of streptozotocin (65 mg/kg) followed by nicotinamide (110 mg/kg). Diabetes-confirmed rats were then given glibenclamide (4.5 mg/kg), C. grandis extract (300 mg/kg), B. balsamifera extract (150 mg/kg), and the combined extracts with a dose ratio of 1:1, 1:3, and 3:1. The treatment was performed for 28 days and fasting blood glucose was tested once a week. The pancreas and liver organs were taken on day 29 for antioxidant, histological, and immunohistochemical assessment.

Results

Among all the extracts, the combined extract with a ratio of 1:3 showed the greatest glucose lowering effect. This combination also lowered malondialdehyde levels while increasing superoxide dismutase and catalase levels in the pancreas and liver organs. Histological examination showed this combination regenerated the islet of Langerhans. It also increased pancreatic insulin expression in immunohistochemical evaluation.

Conclusion

This study revealed that the combined extracts of C. grandis and B. balsamifera exhibited enhanced antidiabetic activity via ameliorating oxidative stress, regenerating β-cells, and increasing insulin expression.

背景:Coccinia grandis 和 Blumea balsamifera 是两种已知具有良好抗糖尿病功效的药用植物。将这两种植物提取物合用可能会产生更大的效果,从而提高疗效并减少剂量:本研究探讨了鹅掌楸和香脂树叶提取物复方制剂对实验性糖尿病大鼠的抗糖尿病活性:将鹅掌楸和香脂树的干燥叶片制成粉末,用 70% 的乙醇(v/v)浸泡。通过腹腔注射单剂量链脲佐菌素(65 毫克/千克)和烟酰胺(110 毫克/千克),雄性 Wistar 白化大鼠出现糖尿病。然后给确诊为糖尿病的大鼠注射格列本脲(4.5 毫克/千克)、大叶桉提取物(300 毫克/千克)、苦参提取物(150 毫克/千克)以及剂量比为 1:1、1:3 和 3:1 的联合提取物。治疗持续 28 天,每周检测一次空腹血糖。第 29 天取胰腺和肝脏器官进行抗氧化、组织学和免疫组化评估:结果:在所有提取物中,比例为 1:3 的组合提取物的降糖效果最好。这种组合还能降低丙二醛水平,同时提高胰腺和肝脏器官中的超氧化物歧化酶和过氧化氢酶水平。组织学检查显示,这种组合可使朗格汉斯胰岛再生。在免疫组化评估中,它还增加了胰岛素的表达:这项研究表明,鹅掌楸和香脂树的联合提取物通过改善氧化应激、再生 β 细胞和增加胰岛素表达,显示出更强的抗糖尿病活性。
{"title":"Antidiabetic effect of combined extract of Coccinia grandis and Blumea balsamifera on streptozotocin-nicotinamide induced diabetic rats","authors":"I Made Wisnu Adhi Putra ,&nbsp;Nanang Fakhrudin ,&nbsp;Arief Nurrochmad ,&nbsp;Subagus Wahyuono","doi":"10.1016/j.jaim.2024.101021","DOIUrl":"10.1016/j.jaim.2024.101021","url":null,"abstract":"<div><h3>Background</h3><p><em>Coccinia grandis</em> and <em>Blumea balsamifera</em> are two medicinal plants that have been known to have good antidiabetic properties. Combining these two plant extracts may generate a greater effect that can increase efficacy and decrease the dose.</p></div><div><h3>Objective</h3><p>This research investigated the antidiabetic activity of the combination of <em>C. grandis</em> and <em>B. balsamifera</em> leaves extracts on experimental diabetic rats.</p></div><div><h3>Materials and methods</h3><p>The dried leaves of <em>C. grandis</em> and <em>B. balsamifera</em> were powdered and macerated with ethanol 70% (v/v). A diabetic condition in male Wistar albino rats was generated by intraperitoneal injection of a single dose of streptozotocin (65 mg/kg) followed by nicotinamide (110 mg/kg). Diabetes-confirmed rats were then given glibenclamide (4.5 mg/kg), <em>C. grandis</em> extract (300 mg/kg), <em>B. balsamifera</em> extract (150 mg/kg), and the combined extracts with a dose ratio of 1:1, 1:3, and 3:1. The treatment was performed for 28 days and fasting blood glucose was tested once a week. The pancreas and liver organs were taken on day 29 for antioxidant, histological, and immunohistochemical assessment.</p></div><div><h3>Results</h3><p>Among all the extracts, the combined extract with a ratio of 1:3 showed the greatest glucose lowering effect. This combination also lowered malondialdehyde levels while increasing superoxide dismutase and catalase levels in the pancreas and liver organs. Histological examination showed this combination regenerated the islet of Langerhans. It also increased pancreatic insulin expression in immunohistochemical evaluation.</p></div><div><h3>Conclusion</h3><p>This study revealed that the combined extracts of <em>C. grandis</em> and <em>B. balsamifera</em> exhibited enhanced antidiabetic activity via ameliorating oxidative stress, regenerating β-cells, and increasing insulin expression.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 4","pages":"Article 101021"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001360/pdfft?md5=9afd3244dd3beb54c049af2aaf294f13&pid=1-s2.0-S0975947624001360-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1